CODIMAL-L.A. 12 Drug Patent Profile
✉ Email this page to a colleague
When do Codimal-l.a. 12 patents expire, and when can generic versions of Codimal-l.a. 12 launch?
Codimal-l.a. 12 is a drug marketed by Schwarz Pharma and is included in one NDA.
The generic ingredient in CODIMAL-L.A. 12 is chlorpheniramine maleate; pseudoephedrine hydrochloride. There are twenty-nine drug master file entries for this compound. Additional details are available on the chlorpheniramine maleate; pseudoephedrine hydrochloride profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CODIMAL-L.A. 12?
- What are the global sales for CODIMAL-L.A. 12?
- What is Average Wholesale Price for CODIMAL-L.A. 12?
Summary for CODIMAL-L.A. 12
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | CODIMAL-L.A. 12 at DailyMed |
US Patents and Regulatory Information for CODIMAL-L.A. 12
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Schwarz Pharma | CODIMAL-L.A. 12 | chlorpheniramine maleate; pseudoephedrine hydrochloride | CAPSULE, EXTENDED RELEASE;ORAL | 018935-001 | Apr 15, 1985 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
